Morality Clinical Trial
Official title:
Predictors of Mortality in Patients With VA-Extracorporeal Membrane Oxygenation. A Retrospective Data Review.
Venoarterial extracorporeal membrane oxygenation (VA-ECMO) support is a lifesaving tool used to treat cardiogenic shock, acute heart failure, or extracorporeal cardiopulmonary resuscitation(CPR). However, its use is associated with significant complications, including mortality. We aim to conduct a retrospective observational study of all patients at Heart Hospital who required VA-ECMO support due to cardiogenic shock during 1/06/2016 and 1/06/2022 to report the incidence of in-hospital mortality among patients who required VA-ECMO along with the predictors of mortality. Data will be collected to identify baseline characteristics and outcomes including clinical variables predictive of poor outcomes.
Extracorporeal membrane oxygenation (ECMO) is an advanced life support modality for critically ill patients with refractory cardiac or respiratory failure. It is a temporary support for cardiorespiratory failure, bridging time for recovery or permanent assist. Besides, ECMO could be used in a variety of clinical presentations, such as severe traumas, extracorporeal-assisted rewarming (ECAR) of accidental deep hypothermia, and can be used as a bridge to lung or heart transplant. Cardiogenic shock can be a fatal condition with poor prognosis. Conventional treatments for cardiogenic shock include vasopressor agents guided by invasive monitoring, and intraaortic balloon pump support. There has been growing interest in the use of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) as a salvage therapy for patients in cardiogenic shock refractory to conventional treatments. However, there is a low rate of survival to weaning or bridging therapy among patients with cardiogenic shock requiring ECMO (42-56%). Moreover, VA-ECMO use is associated with complications, including bleeding, renal failure. Thus, the benefits of this potentially life-saving support is still subject to discussion, especially for VA-ECMO use in the setting of cardiogenic shock as the evidence is scarce. Therefore, it important to identify the patients' related factors that may be associated with poor outcomes using real-world data. We will conduct a retrospective observational study of all patients at Heart Hospital who required VA-ECMO support due to cardiogenic shock during 1/06/2016 and 1/06/2022 with the aim of quantifying the incidence of in-hospital mortality among patients who required VA-ECMO in the setting of cardiogenic shock along with determining the predictors of mortality. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03079726 -
Use of Device Data to Predict Frailty in Individuals
|
||
| Not yet recruiting |
NCT05447611 -
Role of Empathy in Curative Treatment Outcomes of Non-metastatic Colorectal Cancer.
|
||
| Completed |
NCT05268419 -
Efficacy and Safety of Ethanol Inhalation on COVID-19 Treatment (a Clinical Trial Study)
|
Phase 3 | |
| Completed |
NCT05042804 -
Perioperative Outcome Risk Assessment With Computer Learning Enhancement
|
N/A | |
| Recruiting |
NCT03628313 -
Valvular Aortic Stenosis Prognosis Study
|
||
| Completed |
NCT05527678 -
5 Years Quality of Life and Early Mobilization in ICU
|
||
| Recruiting |
NCT05088109 -
Shock Indices Use for Early Mortality From Septic Shock
|
||
| Recruiting |
NCT05073991 -
Incidence of Mortality and Complications After Lung Surgery, Open Thoracic Aortic Repair, TEVAR, EVAR.
|
||
| Completed |
NCT05844410 -
Evaluation of Corticosteroids Use and Clinical Outcomes in Hospitalized COVID-19 Patients: A Retrospective Study
|
||
| Recruiting |
NCT05585593 -
Registry for Hypoparathyroidism Wuerzburg
|
||
| Recruiting |
NCT03834246 -
Smoke Inhalation Injury in Patients Admitted to Intensive Care
|
||
| Completed |
NCT03919032 -
Bacterial Infections in Patients With Cirrhosis in Argentina: Clinical and Microbiological Characteristics
|
||
| Completed |
NCT05116670 -
Comparison of Care Practices, Mortality and Morbidity of Very Preterm Infants Between Two Tertiary Centers in Northwest and South of China
|
||
| Withdrawn |
NCT04531839 -
Improving Outcome of Very Preterm Infants Using Collaborative Quality Improvement
|
N/A | |
| Recruiting |
NCT04685278 -
Anticardiolipin Autoantibodies and Mortality in Septic Patients
|
||
| Not yet recruiting |
NCT03665987 -
The Effect of Preoperative Assessment Clinic on Prognosis and Economic Results of Patients With Coexisting Disease.
|
||
| Completed |
NCT04049565 -
CRP Versus PCT as Bio-markers for Sepsis and in Guiding Antibiotics in Critically Ill Patients
|
||
| Completed |
NCT04971278 -
Evaluating the Impact of a Supportive Care Program
|
||
| Recruiting |
NCT06087315 -
Evaluation of a Multi-country Medical Oxygen Program
|
||
| Completed |
NCT03344627 -
Clinical Outcome Study of High-dose Meropenem in Sepsis and Septic Shock Patients
|
N/A |